Literature DB >> 2467083

Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release.

A Kurtz1, R Della Bruna, J Pratz, I Cavero.   

Abstract

Under control conditions a primary culture containing about 80-90% of granular juxtaglomerular (JG) cells prepared from rat kidneys continuously released renin into the culture medium at a rate of 17.9 +/- 1.4 ng angiotensin I/h per mg of cell proteins per 30 min (n = 14). Dopamine (1.0 microM), the DA-1 dopamine receptor agonist fenoldopam (0.5 microM), and isoproterenol (1.0 microM) increased renin secretion markedly (130-200%). Propranolol (0.1 microM) reduced the effects of isoproterenol significantly (80%), but not those of dopamine or fenoldopam. In contrast, SCH 23390 (0.01 microM), a DA-1 dopamine receptor antagonist, inhibited markedly only the renin release evoked by the latter two agonists, whereas S-sulpiride (10 microM), a DA-2 dopamine receptor antagonist, and phentolamine (10 microM), a nonselective alpha-adrenoceptor antagonist, did not modify the effects of either dopamine or fenoldopam. In rats, pithed to eliminate reflexogenic mechanisms regulating renin release, at the end of a 15 min i.v. infusion of fenoldopam (20 micrograms/kg per min) there was a significant increase in plasma renin activity. This effect was completely prevented by SCH 23390 (0.1 mg/kg i.v.) but not significantly changed by S-sulpiride (0.3 mg/kg i.v.) or phentolamine (3.0 mg/kg i.v.) plus propranolol (0.75 mg/kg i.v.). In conclusion, these results indicate that DA-1 dopamine receptors are present in rat kidney JG cells and that pharmacological stimulation of these receptors with dopamine or fenoldopam leads to renin secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2467083     DOI: 10.1097/00005344-198812000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  Demonstration of dopamine DA-1 receptor sites in rat juxtaglomerular cells by light microscope autoradiography.

Authors:  F Amenta; A Ricci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

3.  Lithium and the renal response to gludopa, fenoldopam and dopamine.

Authors:  A R Girbes; A J Smit; S Meijer; W D Reitsma
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

4.  Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.

Authors:  L D Asico; C Ladines; S Fuchs; D Accili; R M Carey; C Semeraro; F Pocchiari; R A Felder; G M Eisner; P A Jose
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

5.  Biochemical, autoradiographic and pharmacological evidence for the involvement of tubular DA-1 receptors in the natriuretic response to dopexamine hydrochloride.

Authors:  S J Vyas; S Apparsundaram; A Ricci; F Amenta; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

6.  Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.

Authors:  C Chen; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

7.  Intrarenal dopaminergic system regulates renin expression.

Authors:  Ming-Zhi Zhang; Bing Yao; Xiaofeng Fang; Suwan Wang; James P Smith; Raymond C Harris
Journal:  Hypertension       Date:  2009-01-12       Impact factor: 10.190

Review 8.  New roles for renin and prorenin in heart failure and cardiorenal crosstalk.

Authors:  Nicolas F Schroten; Carlo A J M Gaillard; Dirk J van Veldhuisen; Mariusz K Szymanski; Hans L Hillege; Rudolf A de Boer
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.